Amicus Therapeutics (FOLD) had the highest return between May 1, 2014 and January 31, 2015 by a mid-cap US stock, returning 244.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Amicus Therapeutics (FOLD) | 5/1/2014 - 1/31/2015 | 244.84% |
PTC Therapeutics (PTCT) | 5/1/2014 - 1/31/2015 | 183.33% |
Agios Pharm (AGIO) | 5/1/2014 - 1/31/2015 | 170.84% |
TG Therapeutics (TGTX) | 5/1/2014 - 1/31/2015 | 169.19% |
Ocular Therapeutix (OCUL) | 5/1/2014 - 1/31/2015 | 134.46% |
Ambarella (AMBA) | 5/1/2014 - 1/31/2015 | 122.13% |
Qorvo (QRVO) | 5/1/2014 - 1/31/2015 | 118.29% |
Uniqure (QURE) | 5/1/2014 - 1/31/2015 | 102.9% |
Qualys (QLYS) | 5/1/2014 - 1/31/2015 | 96.79% |
Halozyme Therapeutics (HALO) | 5/1/2014 - 1/31/2015 | 93.5% |
Tower Semiconductor (TSEM) | 5/1/2014 - 1/31/2015 | 90.1% |
MACOM Technology Solutions (MTSI) | 5/1/2014 - 1/31/2015 | 86.73% |
ANI Pharmaceuticals (ANIP) | 5/1/2014 - 1/31/2015 | 79.39% |
Xenon Pharmaceuticals (XENE) | 5/1/2014 - 1/31/2015 | 77.54% |
Catalyst Pharmaceuticals (CPRX) | 5/1/2014 - 1/31/2015 | 77.18% |
Silicon Motion Technology (SIMO) | 5/1/2014 - 1/31/2015 | 71.23% |
Century Aluminum (CENX) | 5/1/2014 - 1/31/2015 | 68.56% |
Enphase Energy (ENPH) | 5/1/2014 - 1/31/2015 | 63.89% |
Murphy USA (MUSA) | 5/1/2014 - 1/31/2015 | 63.57% |
Boise Cascad Llc (BCC) | 5/1/2014 - 1/31/2015 | 61.63% |
Vipshop (VIPS) | 5/1/2014 - 1/31/2015 | 59.91% |
Bath & Body Works (BBWI) | 5/1/2014 - 1/31/2015 | 58.23% |
RadNet (RDNT) | 5/1/2014 - 1/31/2015 | 58.12% |
Alkermes (ALKS) | 5/1/2014 - 1/31/2015 | 57.41% |
Cytokinetics (CYTK) | 5/1/2014 - 1/31/2015 | 56.51% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
